From the field of play to the field of combat: A review of the pharmacological management of concussion

Neurosurgery

Volumn 70, Issue 6, 2012, Pages 1520-1533

  Petraglia, Anthony L ^a   Maroon, Joseph C ^b   Bailes, Julian E ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Concussion; Mild traumatic brain injury; Pharmacotherapy; Postconcussive syndrome; Sports; Symptoms

Indexed keywords

ACETYLSALICYLIC ACID; ALSUMA; AMANTADINE; AMITRIPTYLINE; AMPHETAMINE; ATOMOXETINE; CEBERCLON; CITALOPRAM; CITICOLINE; CLONAZEPAM; DEXAMPHETAMINE; DIAZEPAM; DICLOFENAC; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; DIMENHYDRINATE; DONEPEZIL; DRIMINATE; FLUOXETINE; GABAPENTIN; GABAPENTIN ENACARBIL; GABARONE; GALANTAMINE; HEALTH AID MELATONIN; IBUPROFEN; LORAZEPAM; MECLOZINE; MEDIVERT; MELATONIN; METHYLPHENIDATE; METOCLOPRAMIDE; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; MODAFINIL; NAPROXEN; NORTRIPTYLINE; ONDANSETRON; PARACETAMOL; PAROXETINE; PLACEBO; PRAZOSIN; PROCENTRA; PROMETHAGAN; PROMETHAZINE; PROPRANOLOL; RIVASTIGMINE; RIZATRIPTAN; SCOPOLAMINE; SERTRALINE; SGARD; SUMATRIPTAN; SUMATRIPTAN SUCCINATE; TOPIRAGEN; TOPIRAMATE; TRAZODONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPAX; VALPROATE SEMISODIUM; VALPROIC ACID; VANATREX; VESPRO MELATONIN; ZOLMITRIPTAN; ZOLPIDEM TARTRATE;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; AGITATION; ALLERGY; ANXIETY; ANXIETY DISORDER; APPETITE; BACKACHE; BLEEDING; BLURRED VISION; BODY WEIGHT; BRAIN CONCUSSION; BRAIN HEMORRHAGE; CHEST TIGHTNESS; CHRONIC DAILY HEADACHE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONSTIPATION; CONVALESCENCE; COORDINATION DISORDER; DAYTIME SOMNOLENCE; DECREASED APPETITE; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM ULCER; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DRY EYE; DRY THROAT; DYSPNEA; EMOTIONAL DISORDER; EVENING DOSAGE; FATIGUE; FLUSHING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEART RATE; HEARTBURN; HUMAN; HYPERESTHESIA; HYPERTENSION; HYPOTENSION; IMPOTENCE; INJECTION SITE REACTION; INSOMNIA; IRRITABILITY; JAW PAIN; KIDNEY FAILURE; LIVER FAILURE; LONG TERM MEMORY; MAJOR DEPRESSION; MEDICAL LITERATURE; MEMORY DISORDER; MIGRAINE; MOOD DISORDER; MORNING DOSAGE; NAUSEA; NECK PAIN; NERVOUSNESS; NIGHTMARE; NOSE CONGESTION; OCULAR PRURITUS; PARESTHESIA; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC HEADACHE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RESTLESSNESS; REVIEW; SEIZURE; SHORT TERM MEMORY; SIDE EFFECT; SKIN SENSATION; SKIN TINGLING; SLEEP DISORDER; SLEEP WALKING; STOMACH PAIN; SWEATING; SWELLING; SYMPTOM; SYSTEMATIC REVIEW; TACHYCARDIA; TASTE DISORDER; TENSION HEADACHE; TINNITUS; TRAUMATIC BRAIN INJURY; TREATMENT RESPONSE; TREMOR; URINARY FREQUENCY; VERTIGO; VOMITING; WEAKNESS; WEIGHT GAIN; WHEEZING; XEROSTOMIA;

ATHLETIC INJURIES; BRAIN CONCUSSION; HUMANS; NEUROPROTECTIVE AGENTS; WAR;

EID: 84861511451     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31824cebe8     Document Type: Review

References (147)

1. Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: A brief overview. J Head Trauma Rehabil. 2006;21(5): 375-378.
2. Veterans for Commonsense. Iraq and Afghanistan war impact report: number of deployments for those ever deployed for Operation Iraqi Freedom and Operation Enduring Freedom, as of Dec. 31, 2010. http://veteransforcommonsense.org/wp- content/uploads/2012/01/VCS-IAIR-JAN-2012.pdf. Accessed November 23, 2011.
3. Felber ES. Combat-related posttraumatic headache: diagnosis, mechanisms of injury, and challenges to treatment. J Am Osteopath Assoc. 2010;110(12): 737-738.
4. Erickson JC. Treatment outcomes of chronic post-traumatic headaches after mild head trauma in US soldiers: An observational study. Headache. 2011;51(6): 932-944.
5. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med. 2008; 358(5):453-463.
6. Okie S. Traumatic brain injury in the war zone. N Engl J Med. 2005;352(20): 2043-2047.
7. Schwab KA, Ivins B, Cramer G, et al. Screening for traumatic brain injury in troops returning from deployment in Afghanistan and Iraq: initial investigation of the usefulness of a short screening tool for traumatic brain injury. J Head Trauma Rehabil. 2007;22(6):377-389.
8. Terrio H, Brenner LA, Ivins BJ, et al. Traumatic brain injury screening: preliminary findings in a US Army brigade combat team. J Head Trauma Rehabil. 2009;24(1):14-23.
9. Theeler BJ, Flynn FG, Erickson JC. Headaches after concussion in US soldiers returning from Iraq or Afghanistan. Headache. 2010;50(8):1262-1272.
10. Comper P, Bisschop SM, Carnide N, Tricco A. A systematic review of treatments for mild traumatic brain injury. Brain Inj. 2005;19(11):863-880.
11. Hinkle JL, Alves WM, Rimell RW, Jane JA. Restoring social competence in minor head-injury patients. J Neurosci Nurs. 1986;18(5):268-271.
12. McCrea M, Hammeke T, Olsen G, Leo P, Guskiewicz K. Unreported concussion in high school football players: implications for prevention. Clin J Sport Med. 2004;14(1):13-17.
13. Mittenberg W, Canyock EM, Condit D, Patton C. Treatment of postconcussion syndrome following mild head injury. J Clin Exp Neuropsychol. 2001;23(6):829-836.
14. Paniak C, Toller-Lobe G, Durand A, Nagy J. A randomized trial of two treatments for mild traumatic brain injury. Brain Inj. 1998;12(12): 1011-1023.
15. Paniak C, Toller-Lobe G, Reynolds S, Melnyk A, Nagy J. A randomized trial of two treatments for mild traumatic brain injury: 1 year follow-up. Brain Inj. 2000; 14(3):219-226.
16. Ponsford J,Willmott C, Rothwell A, et al. Impact of early intervention on outcome after mild traumatic brain injury in children. Pediatrics. 2001;108(6):1297-1303.
17. Ponsford J, Willmott C, Rothwell A, et al. Impact of early intervention on outcome following mild head injury in adults. J Neurol Neurosurg Psychiatry. 2002;73(3):330-332.
18. Salazar AM. Impact of early intervention on outcome following mild head injury in adults. J Neurol Neurosurg Psychiatry. 2002;73(3):239.
19. Wade DT, Crawford S, Wenden FJ, King NS, Moss NE. Does routine follow up after head injury help? A randomised controlled trial. J Neurol Neurosurg Psychiatry. 1997;62(5):478-484.
20. Wade DT, King NS, Wenden FJ, Crawford S, Caldwell FE. Routine follow up after head injury: A second randomised controlled trial. J Neurol Neurosurg Psychiatry. 1998;65(2):177-183.
21. Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injury: A state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851-879.
22. Meehan WP III. Medical therapies for concussion. Clin Sports Med. 2011;30(1): 115-124, ix.
23. McCrory P, Meeuwisse W, Johnston K, et al. Consensus statement on concussion in sport: the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. Br J Sports Med. 2009;43(suppl 1):i76-i90.
24. Barkhoudarian G, Hovda DA, Giza CC. The molecular pathophysiology of concussive brain injury. Clin Sports Med. 2011;30(1):33-48, vii-iii.
25. Johnson GV, Greenwood JA, Costello AC, Troncoso JC. The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain. Neurochem Res. 1991;16(8):869-873.
26. Mata M, Staple J, Fink DJ. Changes in intra-axonal calcium distribution following nerve crush. J Neurobiol. 1986;17(5):449-467.
27. Maxwell WL, McCreath BJ, Graham DI, Gennarelli TA. Cytochemical evidence for redistribution of membrane pump calcium-ATPase and ecto-Ca-ATPase activity, and calcium influx in myelinated nerve fibres of the optic nerve after stretch injury. J Neurocytol. 1995;24(12):925-942.
28. Maxwell WL, Povlishock JT, Graham DL. A mechanistic analysis of nondisruptive axonal injury: A review. J Neurotrauma. 1997;14(7):419-440.
29. Pettus EH, Povlishock JT. Characterization of a distinct set of intra-axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res. 1996;722(1-2):1-11.
30. Povlishock JT, Pettus EH. Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir Suppl. 1996;66:81-86.
31. Saatman KE, Abai B, Grosvenor A, Vorwerk CK, Smith DH, Meaney DF. Traumatic axonal injury results in biphasic calpain activation and retrograde transport impairment in mice. J Cereb Blood Flow Metab. 2003;23(1):34-42.
32. Spain A, Daumas S, Lifshitz J, et al. Mild fluid percussion injury in mice produces evolving selective axonal pathology and cognitive deficits relevant to human brain injury. J Neurotrauma. 2010;27(8):1429-1438.
33. Katayama Y, Becker DP, Tamura T, Hovda DA. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg. 1990;73(6):889-900.
34. Verweij BH, Muizelaar JP, Vinas FC, Peterson PL, Xiong Y, Lee CP. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111). Neurol Res. 1997;19(3):334-339.
35. Xiong Y, Gu Q, Peterson PL, Muizelaar JP, Lee CP. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma. 1997;14(1):23-34.
36. Len TK, Neary JP. Cerebrovascular pathophysiology following mild traumatic brain injury. Clin Physiol Funct Imaging. 2011;31(2):85-93.
37. Blaylock RL,Maroon J. Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy: A unifying hypothesis. Surg Neurol Int. 2011;2:107.
38. Guskiewicz KM, Marshall SW, Bailes J, et al. Association between recurrent concussion and late-life cognitive impairment in retired professional football players. Neurosurgery. 2005;57(4):719-726; discussion 719-726.
39. Guskiewicz KM, Marshall SW, Bailes J, et al. Recurrent concussion and risk of depression in retired professional football players. Med Sci Sports Exerc. 2007;39 (6):903-909.
40. Omalu B, Bailes J, Hamilton RL, et al. Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery. 2011;69 (1):173-183; discussion 183.
41. Omalu B, Hammers JL, Bailes J, et al. Chronic traumatic encephalopathy in an Iraqi war veteran with posttraumatic stress disorder who committed suicide. Neurosurg Focus. 2011;31(5):E3.
42. Omalu BI, Fitzsimmons RP, Hammers J, Bailes J. Chronic traumatic encephalopathy in a professional American wrestler. J Forensic Nurs. 2010;6(3):130-136.
43. Giza CC, Hovda DA. The neurometabolic cascade of concussion. J Athl Train. 2001;36(3):228-235.
44. Guskiewicz KM, McCrea M, Marshall SW, et al. Cumulative effects associated with recurrent concussion in collegiate football players: the NCAA Concussion Study. JAMA. 2003;290(19):2549-2555.
45. Iverson GL, Brooks BL, Collins MW, Lovell MR. Tracking neuropsychological recovery following concussion in sport. Brain Inj. 2006;20(3):245-252.
46. Willer B, Leddy JJ. Management of concussion and post-concussion syndrome. Curr Treat Options Neurol. 2006;8(5):415-426.
47. McHugh T, Laforce R Jr., Gallagher P, Quinn S, Diggle P, Buchanan L. Natural history of the long-term cognitive, affective, and physical sequelae of mild traumatic brain injury. Brain Cogn. 2006;60(2):209-211.
48. Schnadower D, Vazquez H, Lee J, Dayan P, Roskind CG. Controversies in the evaluation and management of minor blunt head trauma in children. Curr Opin Pediatr. 2007;19(3):258-264.
49. Evans RW. Post-traumatic headaches. Neurol Clin. 2004;22(1):237-249, viii.
50. Bigler ED. Neuropsychology and clinical neuroscience of persistent postconcussive syndrome. J Int Neuropsychol Soc. 2008;14(1):1-22.
51. Sedney CL, Orphanos J, Bailes JE. When to consider retiring an athlete after sports-related concussion. Clin Sports Med. 2011;30(1):189-200, xi.
52. Petraglia AL, Winkler EA, Bailes JE. Stuck at the bench: potential natural neuroprotective compounds for concussion. Surg Neurol Int. 2011;2:146.
53. Maroon JC, Bost JW, Maroon A. Natural anti-inflammatory agents for pain relief. Surg Neurol Int. 2010;1:80.
54. Lewis MD, Bailes J. Neuroprotection for the warrior: dietary supplementation with omega-3 fatty acids. Mil Med. 2011;176(10):1120-1127.
55. Bailes JE, Mills JD. Docosahexaenoic acid reduces traumatic axonal injury in a rodent head injury model. J Neurotrauma. 2010;27(9):1617-1624.
56. Mills JD, Bailes JE, Sedney CL, Hutchins H, Sears B. Omega-3 fatty acid supplementation and reduction of traumatic axonal injury in a rodent head injury model. J Neurosurg. 2011;114(1):77-84.
57. Mills JD, Hadley K, Bailes JE. Dietary supplementation with the omega-3 fatty acid docosahexaenoic acid in traumatic brain injury. Neurosurgery. 2011;68(2): 474-481; discussion 481.
58. Beauchamp K, Mutlak H, Smith WR, Shohami E, Stahel PF. Pharmacology of traumatic brain injury: where is the "golden bullet"? Mol Med. 2008;14(11-12): 731-740.
59. Mittenberg W, Burton DB. A survey of treatments for post-concussion syndrome. Brain Inj. 1994;8(5):429-437.
60. Reddy C. A treatment paradigm for sports concussion. Brain Injury Professional. 2004;4:24-25.
61. Arciniegas DB, Anderson CA, Topkoff J, McAllister TW. Mild traumatic brain injury: A neuropsychiatric approach to diagnosis, evaluation, and treatment. Neuropsychiatr Dis Treat. 2005;1(4):311-327.
62. Faux S, Sheedy J. A prospective controlled study in the prevalence of posttraumatic headache following mild traumatic brain injury. Pain Med. 2008;9(8):1001-1011.
63. Paniak C, Reynolds S, Phillips K, Toller-Lobe G, Melnyk A, Nagy J. Patient complaints within 1 month of mild traumatic brain injury: A controlled study. Arch Clin Neuropsychol. 2002;17(4):319-334.
64. Guskiewicz KM, Weaver NL, Padua DA, Garrett WE Jr. Epidemiology of concussion in collegiate and high school football players. Am J Sports Med. 2000; 28(5):643-650.
65. Guskiewicz KM, Bruce SL, Cantu RC, et al. Recommendations on management of sport-related concussion: summary of the National Athletic Trainers' Association position statement. Neurosurgery. 2004;55(4):891-895; discussion 896.
66. Lane JC, Arciniegas DB. Post-traumatic Headache. Curr Treat Options Neurol. 2002;4(1):89-104.
67. Lenaerts ME, Couch JR. Posttraumatic headache. Curr Treat Options Neurol. 2004;6(6):507-517.
68. Packard RC. Epidemiology and pathogenesis of posttraumatic headache. J Head Trauma Rehabil. 1999;14(1):9-21.
69. Haas DC. Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia. 1996;16(7):486-493.
70. Lew HL, Lin PH, Fuh JL, Wang SJ, Clark DJ, Walker WC. Characteristics and treatment of headache after traumatic brain injury: A focused review. Am J Phys Med Rehabil. 2006;85(7):619-627.
71. Solomon S. Posttraumatic headache. Med Clin North Am. 2001;85(4):987-996, vii-viii.
72. Tyler GS, McNeely HE, Dick ML. Treatment of post-traumatic headache with amitriptyline. Headache. 1980;20(4):213-216.
73. Weiss HD, Stern BJ, Goldberg J. Post-traumatic migraine: chronic migraine precipitated by minor head or neck trauma. Headache. 1991;31(7):451-456.
74. Saran A. Antidepressants not effective in headache associated with minor closed head injury. Int J Psychiatry Med. 1988;18(1):75-83.
75. McBeath JG, Nanda A. Use of dihydroergotamine in patients with postconcussion syndrome. Headache. 1994;34(3):148-151.
76. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the treeš Cell Mol Life Sci. 2007;64(16):2090-2103.
77. Packard RC. Treatment of chronic daily posttraumatic headache with divalproex sodium. Headache. 2000;40(9):736-739.
78. AbendNS, NanceML, Bonnemann C. Subcutaneous sumatriptan in an adolescent with acute posttraumatic headache. J Child Neurol. 2008;23(4):438-440.
79. Cohen SP, Plunkett AR, Wilkinson I, et al. Headaches during war: Analysis of presentation, treatment, and factors associated with outcome. Cephalalgia. 2012; 32(2):94-108.
80. Gawel MJ, Rothbart P, Jacobs H. Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache. Headache. 1993;33(2):96-97.
81. Sheftell FD, Weeks RE, Rapoport AM, Siegel S, Baskin S, Arrowsmith F. Subcutaneous sumatriptan in a clinical setting: the first 100 consecutive patients with acute migraine in a tertiary care center. Headache. 1994;34(2):67-72.
82. Tepper SJ, Millson D. Safety profile of the triptans. Expert Opin Drug Saf. 2003; 2(2):123-132.
83. Tepper SJ. Safety and rational use of the triptans. Med Clin North Am. 2001;85 (4):959-970.
84. Rapoport AM, Tepper SJ. Triptans are all different. Arch Neurol. 2001;58(9): 1479-1480.
85. Cicerone KD, Kalmar K. Persistent postconcussion syndrome: the structure of subjective complaints after mild traumatic brain injury. J Head Trauma Rehabil. 1995;10(3):1-17.
86. Zee DS. Perspectives on the pharmacotherapy of vertigo. Arch Otolaryngol. 1985; 111(9):609-612.
87. Hoffer ME, Gottshall KR, Moore R, Balough BJ, Wester D. Characterizing and treating dizziness after mild head trauma. Otol Neurotol. 2004;25(2):135-138.
88. Gottshall KR, Hoffer ME. Tracking recovery of vestibular function in individuals with blast-induced head trauma using vestibular-visual-cognitive interaction tests. J Neurol Phys Ther. 2010;34(2):94-97.
89. Gottshall K. Vestibular rehabilitation after mild traumatic brain injury with vestibular pathology. NeuroRehabilitation. 2011;29(2):167-171.
90. Alsalaheen BA, Mucha A, Morris LO, et al. Vestibular rehabilitation for dizziness and balance disorders after concussion. J Neurol Phys Ther. 2010;34(2): 87-93.
91. Wheaton P, Mathias JL, Vink R. Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: A meta-analysis. J Clin Psychopharmacol. 2011;31(6):745-757.
92. Kaiser PR, Valko PO, Werth E, et al. Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology. 2010;75(20):1780- 1785.
93. Jha A, Weintraub A, Allshouse A, et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil. 2008;23(1):52-63.
94. Frenette AJ, Kanji S, Rees L, et al. Efficacy and safety of dopamine agonists in traumatic brain injury: A systematic review of randomized controlled trials. J Neurotrauma. 2012;29(1):1-18.
95. Management of Concussion/mTBI Working Group. VA/DoD clinical practice guideline for management of concussion/mild traumatic brain injury. J Rehabil Res Dev. 2009;46(6):CP1-CP68.
96. Rao V, Rollings P. Sleep disturbances following traumatic brain injury. Curr Treat Options Neurol. 2002;4(1):77-87.
97. Flanagan SR, Greenwald B,Wieber S. Pharmacological treatment of insomnia for individuals with brain injury. J Head Trauma Rehabil. 2007;22(1):67-70.
98. Ruff RL, Ruff SS, Wang XF. Improving sleep: initial headache treatment in OIF/OEF veterans with blast-induced mild traumatic brain injury. J Rehabil Res Dev. 2009;46(9):1071-1084.
99. Reiter RJ, Korkmaz A. Clinical aspects of melatonin. Saudi Med J. 2008;29(11): 1537-1547.
100. Samantaray S, Das A, Thakore NP, et al. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res. 2009;47(2):134-142.
101. Orff HJ, Ayalon L, Drummond SP. Traumatic brain injury and sleep disturbance: A review of current research. J Head Trauma Rehabil. 2009;24(3): 155-165.
102. Maldonado MD, Murillo-Cabezas F, Terron MP, et al. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res. 2007;42(1):1-11.
103. Kemp S, Biswas R, Neumann V, Coughlan A. The value of melatonin for sleep disorders occurring post-head injury: A pilot RCT. Brain Inj. 2004;18(9):911-919.
104. Buscemi N, Vandermeer B, Pandya R, et al. Melatonin for treatment of sleep disorders. Evid Rep Technol Assess (Summ). 2004;(108):1-7.
105. Medline Plus. Melatonin. 2010. http://www.nlm.nih.gov/medlineplus/ druginfo/natural/940.html. Accessed November 23, 2011.
106. Buscemi N, Vandermeer B, Hooton N, et al. The efficacy and safety of exogenous melatonin for primary sleep disorders: A meta-analysis. J Gen Intern Med. 2005;20(12):1151-1158.
107. Rogers NL, Dinges DF, Kennaway DJ, Dawson D. Potential action of melatonin in insomnia. Sleep. 2003;26(8):1058-1059.
108. Warden DL, Gordon B, McAllister TW, et al. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma. 2006;23(10):1468-1501.
109. Silver JM, McAllister TW, Arciniegas DB. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry. 2009;166(6):653-661.
110. Dinan TG, Mobayed M. Treatment resistance of depression after head injury: A preliminary study of amitriptyline response. Acta Psychiatr Scand. 1992;85(4): 292-294.
111. Saran AS. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants. J Clin Psychiatry. 1985;46(8):335-338.
112. Fann JR, Uomoto JM, Katon WJ. Sertraline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000;12 (2):226-232.
113. Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42(1): 48-54.
114. Rapoport MJ, Chan F, Lanctot K, Herrmann N, McCullagh S, Feinstein A. An open-label study of citalopram for major depression following traumatic brain injury. J Psychopharmacol. 2008;22(8):860-864.
115. Rapoport MJ, Mitchell RA, McCullagh S, et al. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury. J Clin Psychiatry. 2010;71(9):1125-1130.
116. Muller U, Murai T, Bauer-Wittmund T, von Cramon DY. Paroxetine versus citalopram treatment of pathological crying after brain injury. Brain Inj. 1999;13 (10):805-811.
117. Horsfield SA, Rosse RB, Tomasino V, Schwartz BL, Mastropaolo J, Deutsch SI. Fluoxetine's effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med. 2002;32(4):337-344.
118. Collins MW, Grindel SH, Lovell MR, et al. Relationship between concussion and neuropsychological performance in college football players. JAMA. 1999;282 (10):964-970.
119. Collins MW, Lovell MR, McKeag DB. Current issues in managing sports-related concussion. JAMA. 1999;282(24):2283-2285.
120. Van Kampen DA, Lovell MR, Pardini JE, Collins MW, Fu FH. The "value added" of neurocognitive testing after sports-related concussion. Am J Sports Med. 2006;34(10):1630-1635.
121. Plenger PM, Dixon CE, Castillo RM, Frankowski RF, Yablon SA, Levin HS. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil. 1996;77(6):536-540.
122. Tenovuo O. Pharmacological enhancement of cognitive and behavioral deficits after traumatic brain injury. Curr Opin Neurol. 2006;19(6):528-533.
123. Whyte J, Hart T, Schuster K, Fleming M, Polansky M, Coslett HB. Effects of methylphenidate on attentional function after traumatic brain injury: A randomized, placebo-controlled trial. Am J Phys Med Rehabil. 1997;76(6):440-450.
124. Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: A multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83(6):401-420.
125. Williams SE, Ris MD, Ayyangar R, Schefft BK, Berch D. Recovery in pediatric brain injury: is psychostimulant medication beneficial? J Head Trauma Rehabil. 1998;13(3):73-81.
126. Leone H, Polsonetti BW. Amantadine for traumatic brain injury: does it improve cognition and reduce agitation? J Clin Pharm Ther. 2005;30(2):101-104.
127. Sawyer E, Mauro LS, Ohlinger MJ. Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother. 2008;42(2): 247-252.
128. Kraus MF, Smith GS, Butters M, et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: A study using positron emission tomography (PET). Brain Inj. 2005;19(7):471-479.
129. Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4): 300-313.
130. Beers SR, Skold A, Dixon CE, Adelson PD. Neurobehavioral effects of amantadine after pediatric traumatic brain injury: A preliminary report. J Head Trauma Rehabil. 2005;20(5):450-463.
131. Green LB, Hornyak JE, Hurvitz EA. Amantadine in pediatric patients with traumatic brain injury: A retrospective, case-controlled study. Am J Phys Med Rehabil. 2004;83(12):893-897.
132. Schneider WN, Drew-Cates J, Wong TM, Dombovy ML. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: An initial double-blind placebo-controlled study. Brain Inj. 1999;13(11):863-872.
133. Kaye NS, Townsend JB III, Ivins R. An open-label trial of donepezil (Aricept) in the treatment of persons with mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2003;15(3):383-384; author reply 384-385.
134. Masanic CA, Bayley MT, VanReekum R, Simard M. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil. 2001;82(7): 896-901.
135. Walker W, Seel R, Gibellato M, et al. The effects of donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj. 2004;18(8):739-750.
136. Whelan FJ, Walker MS, Schultz SK. Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Ann Clin Psychiatry. 2000;12 (3):131-135.
137. Noble JM, HauserWA. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 2007;68(20):1749; author reply 1750.
138. Silver JM, Koumaras B, ChenM, et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology. 2006;67(5):748-755.
139. Silver JM, Koumaras B, Meng X, et al. Long-term effects of rivastigmine capsules in patients with traumatic brain injury. Brain Inj. 2009;23(2):123-132.
140. Tenovuo O. Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury: clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(1):61-67.
141. Tenovuo O, Alin J, Helenius H. A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury: what it showed and taught? Brain Inj. 2009;23(6):548-558.
142. Zhang L, Plotkin RC, Wang G, Sandel ME, Lee S. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil. 2004;85(7):1050-1055.
143. Levin HS. Treatment of postconcussional symptoms with CDP-choline. J Neurol Sci. 1991;103(suppl):S39-S42.
144. Carlson K, Kehle S, Meis L, et al. The Assessment and Treatment of Individuals With History of Traumatic Brain Injury and Post-Traumatic Stress Disorder: A Systematic Review of the Evidence. Washington, DC: Department of Veterans Affairs; 2009. VA Evidence-Based Synthesis Program Reports.
145. Simmons AN, Matthews SC. Neural circuitry of PTSD with or without mild traumatic brain injury: A meta-analysis. Neuropharmacology. 2012;62(2):598-606.
146. Kamnaksh A, Kovesdi E, Kwon SK, et al. Factors affecting blast traumatic brain injury. J Neurotrauma. 2011;28(10):2145-2153.
147. Carlson KF, Kehle SM, Meis LA, et al. Prevalence, assessment, and treatment of mild traumatic brain injury and posttraumatic stress disorder: A systematic review of the evidence. J Head Trauma Rehabil. 2011;26(2):103-115.